Tower Research Capital LLC (Trc) Kodiak Sciences Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,124 shares of KOD stock, worth $25,023. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,124
Previous 14,637
78.66%
Holding current value
$25,023
Previous $34,000
76.47%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding KOD
# of Institutions
98Shares Held
39MCall Options Held
6.5KPut Options Held
5.8K-
Baker Bros. Advisors LP New York, NY17.3MShares$139 Million0.48% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$30.8 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.95MShares$15.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$13.5 Million0.0% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.02MShares$8.15 Million0.06% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $417M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...